Related Experiment Video

Updated: Jun 27, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

Therapeutic and predictive targets of AKI

R Yalavarthy1, C L Edelstein

  • 1Department of Kidney Diseases, University of Colorado at Denver and Health Sciences Center, Denver, CO 80045, USA.

Clinical Nephrology
|December 4, 2008
PubMed

Insights

Acute kidney injury (AKI), a common hospital condition, significantly increases mortality risk. This review explores molecular targets for improved therapies and earlier diagnosis of AKI.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathophysiology

Background:

  • Acute kidney injury (AKI) is a prevalent clinical syndrome in hospitalized patients.
  • AKI independently elevates the risk of in-hospital mortality.
  • Understanding the molecular underpinnings of AKI is crucial for clinical management.

Purpose of the Study:

  • To review the tubular, inflammatory, and vascular molecular targets implicated in AKI.
  • To identify potential therapeutic strategies aimed at reducing AKI-associated mortality.
  • To highlight biomarkers for the earlier diagnosis of acute kidney injury.

Main Methods:

  • Literature review of molecular targets in acute kidney injury.
  • Analysis of existing research on AKI pathophysiology.
  • Synthesis of information on therapeutic and diagnostic advancements.

Main Results:

  • Identification of key molecular pathways in tubular, inflammatory, and vascular compartments of AKI.
  • Potential therapeutic targets that could mitigate AKI progression and mortality.
  • Emerging biomarkers for prompt AKI detection.

Conclusions:

  • Targeting specific molecular pathways in AKI holds promise for novel therapies.
  • Earlier diagnosis through biomarkers can lead to timely interventions.
  • Further research into these molecular targets may significantly improve patient outcomes in AKI.

More Related Videos

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: